Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues $ 5,207
Cost of revenues (3,818)
Gross profit 1,389
Research and development expenses (9,863) (756)
Sales and marketing expenses (3,058) (667)
General and administrative expenses (2,729) (2,093)
Operating loss (14,261) (3,516)
Financing expenses, net (14,312) (5,333)
Share in losses of affiliated companies accounted for under equity method, net (1,200) (2,966)
Net loss for the year $ (29,773) $ (11,815)
Basic and diluted net loss per share $ (0.11) $ (0.13)
Weighted average number of ordinary shares outstanding attributable to ordinary shareholders 259,176,541 92,024,188